Kazuyuki Tobe

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 20

Top Topics

Rheumatoid Arthritis

Body Mass Index

Glycemic Control

Top Venues

Journal of diabetes investigation

Diabetology international

Arthritis & rheumatology (Hoboken, N.J.)

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Allah Nawaz, Shiho Fujisaka, Tomonobu Kado, Ishtiaq Jeelani, Kazuyuki Tobe
Heterogeneity of adipose tissue-resident macrophages-beyond M1/M2 paradigm. Diabetology international 14 (2) (2023)
Asako Enkaku, Daisuke Chujo, Miki Kamigishi, Shinya Inagawa, Shinnosuke Matsukoshi, Waka Sakai, Akiko Takikawa, Shiho Fujisaka, Kazuyuki Tobe
Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients. Journal of diabetes investigation 15 (4) (2023)
Allah Nawaz, Shiho Fujisaka, Tomonobu Kado, Ishtiaq Jeelani, Kazuyuki Tobe
Heterogeneity of adipose tissue-resident macrophages-beyond M1/M2 paradigm. Diabetology international 14 (2) (2023)
Allah Nawaz, Shiho Fujisaka, Tomonobu Kado, Ishtiaq Jeelani, Kazuyuki Tobe
Heterogeneity of adipose tissue-resident macrophages-beyond M1/M2 paradigm. Diabetology international 14 (2) (2023)
Asako Enkaku, Daisuke Chujo, Miki Kamigishi, Shinya Inagawa, Shinnosuke Matsukoshi, Waka Sakai, Akiko Takikawa, Shiho Fujisaka, Kazuyuki Tobe
Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients. Journal of diabetes investigation 15 (4) (2023)
Asako Enkaku, Daisuke Chujo, Miki Kamigishi, Shinya Inagawa, Shinnosuke Matsukoshi, Waka Sakai, Akiko Takikawa, Shiho Fujisaka, Kazuyuki Tobe
Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients. Journal of diabetes investigation (2023)
Allah Nawaz, Shiho Fujisaka, Tomonobu Kado, Ishtiaq Jeelani, Kazuyuki Tobe
Heterogeneity of adipose tissue-resident macrophages-beyond M1/M2 paradigm. Diabetology international 14 (2) (2023)
Asako Enkaku, Daisuke Chujo, Miki Kamigishi, Shinya Inagawa, Shinnosuke Matsukoshi, Waka Sakai, Akiko Takikawa, Shiho Fujisaka, Kazuyuki Tobe
Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients. Journal of diabetes investigation 15 (4) (2023)
Masataka Shikata, Daisuke Chujo, Asako Enkaku, Akiko Takikawa-Nishida, Hisae Honoki, Shinnosuke Yamada-Matsukoshi, Maki Nakagawa-Yokoyama, Miki Kamigishi, Shinya Inagawa, Shiho Fujisaka, Kunimasa Yagi, Kazuto Shibuya, Tsutomu Fujii, Kazuyuki Tobe
Perioperative C-peptide index is associated with the status of diabetes management after pancreatectomy. Journal of diabetes investigation 13 (10) (2022)
Kunimasa Yagi, Teruhiko Imamura, Hayato Tada, Jianhui Liu, Yukiko Miyamoto, Azusa Ohbatake, Naoko Ito, Masataka Shikata, Asako Enkaku, Akiko Takikawa, Hisae Honoki, Shiho Fujisaka, Daisuke Chujo, Hideki Origasa, Koichiro Kinugawa, Kazuyuki Tobe
Fragmented QRS on electrocardiography as a predictor for diastolic cardiac dysfunction in type 2 diabetes. Journal of diabetes investigation 13 (6) (2022)
Koichiro Shinoda, Yasuhito Hamaguchi, Kazuyuki Tobe
Widespread Mechanic's Hands in Antisynthetase Syndrome With Anti-OJ Antibody. The Journal of rheumatology 48 (8) (2021)
Kunimasa Yagi, Yoshiki Nagata, Takashi Yamagami, Daisuke Chujo, Miki Kamigishi, Maki Yokoyama-Nakagawa, Masataka Shikata, Asako Enkaku, Akiko Takikawa-Nishida, Hisae Honoki, Shiho Fujisaka, Hideki Origasa, Kazuyuki Tobe
High prevalence of fragmented QRS on electrocardiography in Japanese patients with diabetes irrespective of metabolic syndrome. Journal of diabetes investigation 12 (9) (2021)
Keiichi Koizumi, Makito Oku, Shusaku Hayashi, Akiko Inujima, Naotoshi Shibahara, Luo-Nan Chen, Yoshiko Igarashi, Kazuyuki Tobe, Shigeru Saito, Makoto Kadowaki, Kazuyuki Aihara
Corrigendum to "Suppression of Dynamical Network Biomarker Signals at the Predisease State (Mibyou) before Metabolic Syndrome in Mice by a Traditional Japanese Medicine (Kampo Formula) Bofutsushosan". Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Tatsuhiko Ozawa, Kazuhisa Ouhara, Reina Tsuda, Syuichi Munenaga, Hidemi Kurihara, Hiroki Kohno, Hiroshi Hamana, Eiji Kobayashi, Hirofumi Taki, Kazuyuki Tobe, Eiji Sugiyama, Atsushi Muraguchi, Hiroyuki Kishi
Physiologic Target, Molecular Evolution, and Pathogenic Functions of a Monoclonal Anti-Citrullinated Protein Antibody Obtained From a Patient With Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.) 72 (12) (2020)
Akiko Takikawa, Isao Usui, Shiho Fujisaka, Koichi Tsuneyama, Keisuke Okabe, Takashi Nakagawa, Allah Nawaz, Tomonobu Kado, Teruo Jojima, Yoshimasa Aso, Yoshihiro Hayakawa, Kunikimi Yagi, Kazuyuki Tobe
Macrophage-specific hypoxia-inducible factor-1α deletion suppresses the development of liver tumors in high-fat diet-fed obese and diabetic mice. Journal of diabetes investigation 10 (6) (2019)
Minoru Iwata, Yutaka Kamura, Hisae Honoki, Kaori Kobayashi, Manabu Ishiki, Kunimasa Yagi, Yasuo Fukushima, Atsuko Takano, Hiromi Kato, Shihou Murakami, Kiyohiro Higuchi, Chikaaki Kobashi, Kazuhito Fukuda, Yukiko Koshimizu, Kazuyuki Tobe
Family history of diabetes in both parents is strongly associated with impaired residual β-cell function in Japanese type 2 diabetes patients. Journal of diabetes investigation 11 (3) (2019)
Allah Nawaz, Kazuyuki Tobe
M2-like macrophages serve as a niche for adipocyte progenitors in adipose tissue. Journal of diabetes investigation 10 (6) (2019)
Hisae Honoki, Kunimasa Yagi, Kenta Kambara, Daisuke Chujo, Masataka Shikata, Asako Enkaku, Akiko Takikawa-Nishida, Jianhui Liu, Shiho Fujisaka, Kazuyuki Tobe
Anti-programmed death ligand 1 therapy-induced type 1 diabetes presenting with multiple islet-related autoantibodies. Journal of diabetes investigation 11 (1) (2019)
Kazuyuki Tobe, Hiroshi Maegawa, Hiromi Tabuchi, Ichiro Nakamura, Satoshi Uno
Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3-month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long-term Use study. Journal of diabetes investigation 10 (5) (2019)
Kazuyuki Tobe, Hideki Suganami, Kohei Kaku
Sodium-glucose cotransporter 2 inhibitor, tofogliflozin, shows better improvements of blood glucose and insulin secretion in patients with high insulin levels at baseline. Journal of diabetes investigation 9 (4) (2017)